Interview 26 May 2021
Immuno-Oncology: From Science Fiction to the Mainstream
In just a couple of decades, immuno-oncology has taken center stage in the biotechnology industry. We discuss the evolution of…
Interview
- Latest Posts
Interview 19 May 2021
Are Biotech Startups Ready for Augmented Reality?
Augmented reality is starting to become a part of the manufacturing process of pharma and biotech companies. Paul Haimes, Vice…
Interview 10 May 2021
The Rollercoaster of Repurposing an Arthritis Drug for Covid-19
The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs into vaccines and treatments for…
Interview 21 Apr 2021
Changing Attitudes on Vaccine and Public Health Investment
The Covid-19 pandemic has pushed investment and research into vaccines and public health, but will such interest continue in the…
ADVERTISEMENT
Interview 5 Apr 2021
Base Editing: The Next Frontier in Genome Editing Technology
Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights into the promises of base…
Interview 15 Mar 2021
Developing a Vaccine that Protects Against Covid-19 Variants
Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs around the world, recent mutations…
Interview 3 Mar 2021
The Promises of CRISPR Genome Editing in Biomedicine
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the advantages of CRISPR gene editing…
Interview 22 Feb 2021
How Automation Can Augment Drug Discovery Research
Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO and co-founder of Arctoris, discusses…
Interview 1 Feb 2021
Democratized DNA Synthesis: A Game-Changer Against Covid-19
DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions during lockdowns. Thomas Ybert, CEO…
Interview 23 Nov 2020
CDMOs Are the Unsung Heroes of the Gene and Cell Therapy Revolution
Cell and gene therapy is booming amid the ongoing pandemic, and this is driving up demand for synthetic DNA products,…
ADVERTISEMENT
Interview 28 Oct 2020
Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come with a number of setbacks,…
Interview 5 Oct 2020
How is Germany Meeting Patient Demand for Medical Cannabis?
Since Germany legalized cannabis for medical use in 2017, we have frequently spoken to Peter Homberg, Partner and Head of…
Interview 28 Sep 2020
From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood cancer, has revolutionized both oncology…
Interview 9 Sep 2020
Biotech Investment in Norway: An Alternative Approach
Norway has not typically been an attractive region for biotech investors, so when Masha Strømme set up her own investment…
Interview 2 Sep 2020
An Alzheimer’s Vaccine Challenged the Consensus for 25 Years
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A team of scientists in Slovakia…
Interview 29 Jul 2020
Medical Cannabis: Regulatory Issues, Patient Demand, and Pricing Changes in Germany
While the coronavirus pandemic has shaken many industries to their core, the European medical cannabis industry continues to flourish. A…
ADVERTISEMENT
Interview 21 May 2020
What 2019 Can Teach About European Biotech Investments Going Forward
Following 2018’s bumper harvest for equity funding in European biotech, 2019 proved even more lucrative, particularly for private biotech companies.…
Interview 15 Apr 2020
Investing in the Microbiome in the Age of Covid-19 and Beyond
For Isabelle de Cremoux, CEO and Managing Partner at Seventure Partners, 2020 was going to be an important year for…
Interview 23 Mar 2020
Riding the Wave of Cambridge Entrepreneurship
The University of Cambridge is world-famous, but unlike its US equivalent, the city isn’t as well known for its startup…
Interview 12 Feb 2020
Boosting Cancer Research by Unlocking Genomic Data
More genomic data is produced today than ever before as it’s fundamental to the development of new medicines. But although…
